Yoon Jee Hee, Park Ji Yong, Hong A Ram, Kim Sung Sun, Kim Hee Kyung, Kang Ho-Cheol
Department of Internal Medicine, Chonnam University Medical School, Hwasun, Republic of Korea.
Division of Endocrinology and Metabolism, Chonnam National University Hwasun Hospital, Hwasun, Republic of Korea.
Front Endocrinol (Lausanne). 2025 May 5;16:1550831. doi: 10.3389/fendo.2025.1550831. eCollection 2025.
Metastasis of thyroid carcinoma to the paranasal sinuses is extremely rare. Herein, a case of clinically occult thyroid cancer arising from a long-standing thyroid nodule that metastasized to the sphenoid sinus is presented, accompanied by a literature review.
A 48-year-old woman visited to the otorhinolaryngology department with visual disturbance and partial nasal obstruction. Computed tomography imaging revealed a tumor in the right sphenoid sinus with adjacent bony destruction, suggestive of paranasal sinus cancer. Thyroid ultrasonography (US) was performed to identify the primary cancer, revealing a thyroid nodule previously diagnosed as a benign follicular nodule 11 years prior. Histopathological examination confirmed minimally invasive follicular thyroid carcinoma (FTC) and poorly differentiated thyroid carcinoma with sphenoid sinus metastasis. Lenvatinib therapy was initiated after total thyroidectomy and radioactive iodine (RAI) therapy, achieving stable disease for 29 months. The patient ultimately succumbed to newly developed brain metastasis with cerebral infarction, 31 months after the initial diagnosis. A literature review of 19 cases revealed that FTC was the most common type (68.5%), followed by papillary thyroid carcinoma (31.6%). Among the 12 cases with assessable clinical outcomes, three patients achieved remission, while nine had persistent disease, with four confirmed deaths.
Diagnosis of paranasal sinus metastasis from thyroid cancer is often delayed due to its rarity and is commonly associated with widespread disseminated disease, resulting in a poor prognosis. Careful follow-up of large thyroid nodules and clinical suspicion of unusual metastasis is essential for early detection of malignancy and metastasis. Multidisciplinary collaboration and various treatment approaches can improve treatment efficacy.
甲状腺癌转移至鼻窦极为罕见。本文报告1例源于长期存在的甲状腺结节且转移至蝶窦的临床隐匿性甲状腺癌病例,并进行文献复习。
一名48岁女性因视力障碍和部分鼻塞就诊于耳鼻喉科。计算机断层扫描成像显示右侧蝶窦有一肿瘤,伴有相邻骨质破坏,提示鼻窦癌。行甲状腺超声检查以确定原发癌,结果显示11年前曾被诊断为良性滤泡性腺瘤的甲状腺结节。组织病理学检查确诊为微侵袭性滤泡状甲状腺癌(FTC)及伴有蝶窦转移的低分化甲状腺癌。在全甲状腺切除及放射性碘(RAI)治疗后开始使用乐伐替尼治疗,病情稳定29个月。患者最终在初次诊断31个月后因新发脑转移合并脑梗死死亡。对19例病例的文献复习显示,FTC是最常见的类型(68.5%),其次是乳头状甲状腺癌(31.6%)。在12例有可评估临床结局的病例中,3例患者病情缓解,9例病情持续,4例确诊死亡。
由于甲状腺癌转移至鼻窦罕见,其诊断常被延迟,且通常与广泛播散性疾病相关,导致预后不良。对大型甲状腺结节进行仔细随访并对不寻常转移保持临床怀疑对于早期发现恶性肿瘤及转移至关重要。多学科协作及多种治疗方法可提高治疗效果。